Matinas BioPharma Holdings Inc

Market Cap

$6M

Healthcare·Biotechnology·🇺🇸 United States·AMEX

Healthcare·Biotechnology·🇺🇸·AMEX

Stock Price

$0.63+$0.01 (+1.77%)

Jun 22, 2026

52W High $2.3652W Low $0.49

Company Details

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lip...

Leadership

Jerome D. Jabbour J.D.Founder

Co-Founder, Chairman, CEO, President & Interim CFO

IPO Date

Aug 18, 2014

Website

www.matinasbiopharma.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$11M

EPS (Diluted)

Free Cash Flow

-$7M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee